Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 73

1.

The ABCG2 resistance network of glioblastoma.

Bleau AM, Huse JT, Holland EC.

Cell Cycle. 2009 Sep 15;8(18):2936-44. Epub 2009 Sep 13. Review.

PMID:
19713741
[PubMed - indexed for MEDLINE]
Free Article
2.

Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme.

Broadley KW, Hunn MK, Farrand KJ, Price KM, Grasso C, Miller RJ, Hermans IF, McConnell MJ.

Stem Cells. 2011 Mar;29(3):452-61. doi: 10.1002/stem.582.

PMID:
21425408
[PubMed - indexed for MEDLINE]
Free Article
3.

Downregulation of ABCG2 expression in glioblastoma cancer stem cells with miRNA-328 may decrease their chemoresistance.

Li WQ, Li YM, Tao BB, Lu YC, Hu GH, Liu HM, He J, Xu Y, Yu HY.

Med Sci Monit. 2010 Oct;16(10):HY27-30.

PMID:
20885358
[PubMed - indexed for MEDLINE]
4.

Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic.

Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool K, Tang DG.

Cancer Res. 2005 Jul 15;65(14):6207-19.

PMID:
16024622
[PubMed - indexed for MEDLINE]
Free Article
5.

Dofequidar fumarate sensitizes cancer stem-like side population cells to chemotherapeutic drugs by inhibiting ABCG2/BCRP-mediated drug export.

Katayama R, Koike S, Sato S, Sugimoto Y, Tsuruo T, Fujita N.

Cancer Sci. 2009 Nov;100(11):2060-8. doi: 10.1111/j.1349-7006.2009.01288.x. Epub 2009 Jul 17.

PMID:
19673889
[PubMed - indexed for MEDLINE]
6.

ABCG2 is related with the grade of glioma and resistance to mitoxantone, a chemotherapeutic drug for glioma.

Jin Y, Bin ZQ, Qiang H, Liang C, Hua C, Jun D, Dong WA, Qing L.

J Cancer Res Clin Oncol. 2009 Oct;135(10):1369-76. doi: 10.1007/s00432-009-0578-4. Epub 2009 Apr 2.

PMID:
19340456
[PubMed - indexed for MEDLINE]
7.

The side population of gliomas exhibits decreased cell migration.

Weber K, Paulus W, Senner V.

J Neuropathol Exp Neurol. 2010 Jun;69(6):623-31. doi: 10.1097/NEN.0b013e3181e04739.

PMID:
20467330
[PubMed - indexed for MEDLINE]
8.

Glioblastoma cancer stem cells: heterogeneity, microenvironment and related therapeutic strategies.

Denysenko T, Gennero L, Roos MA, Melcarne A, Juenemann C, Faccani G, Morra I, Cavallo G, Reguzzi S, Pescarmona G, Ponzetto A.

Cell Biochem Funct. 2010 Jul;28(5):343-51. doi: 10.1002/cbf.1666. Review.

PMID:
20535838
[PubMed - indexed for MEDLINE]
9.

Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens.

Xu Q, Liu G, Yuan X, Xu M, Wang H, Ji J, Konda B, Black KL, Yu JS.

Stem Cells. 2009 Aug;27(8):1734-40. doi: 10.1002/stem.102.

PMID:
19536809
[PubMed - indexed for MEDLINE]
Free Article
10.

Side population in MDA-MB-231 human breast cancer cells exhibits cancer stem cell-like properties without higher bone-metastatic potential.

Hiraga T, Ito S, Nakamura H.

Oncol Rep. 2011 Jan;25(1):289-96.

PMID:
21109989
[PubMed - indexed for MEDLINE]
11.

Gliomagenesis: a game played by few players or a team effort?

Mazzoleni S, Galli R.

Front Biosci (Elite Ed). 2012 Jan 1;4:205-13. Review.

PMID:
22201865
[PubMed - indexed for MEDLINE]
12.

Pediatric brain tumor cancer stem cells: cell cycle dynamics, DNA repair, and etoposide extrusion.

Hussein D, Punjaruk W, Storer LC, Shaw L, Othman R, Peet A, Miller S, Bandopadhyay G, Heath R, Kumari R, Bowman KJ, Braker P, Rahman R, Jones GD, Watson S, Lowe J, Kerr ID, Grundy RG, Coyle B.

Neuro Oncol. 2011 Jan;13(1):70-83. doi: 10.1093/neuonc/noq144. Epub 2010 Oct 25. Erratum in: Neuro Oncol. 2012 Dec;14(12):1528. Ottoman, Ramadan [corrected to Othman, Ramadhan].

PMID:
20978004
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Glioblastoma and stem cells.

Altaner C.

Neoplasma. 2008;55(5):369-74. Review.

PMID:
18665745
[PubMed - indexed for MEDLINE]
14.

Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma.

Kang MK, Kang SK.

Stem Cells Dev. 2007 Oct;16(5):837-47.

PMID:
17999604
[PubMed - indexed for MEDLINE]
15.

The expression and functional characterization of ABCG2 in brain endothelial cells and vessels.

Zhang W, Mojsilovic-Petrovic J, Andrade MF, Zhang H, Ball M, Stanimirovic DB.

FASEB J. 2003 Nov;17(14):2085-7. Epub 2003 Sep 4.

PMID:
12958161
[PubMed - indexed for MEDLINE]
Free Article
16.

Heterogeneity of cancer-initiating cells within glioblastoma.

Binda E, Visioli A, Reynolds B, Vescovi AL.

Front Biosci (Schol Ed). 2012 Jun 1;4:1235-48. Review.

PMID:
22652868
[PubMed - indexed for MEDLINE]
17.

Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma.

Pistollato F, Abbadi S, Rampazzo E, Persano L, Della Puppa A, Frasson C, Sarto E, Scienza R, D'avella D, Basso G.

Stem Cells. 2010 May;28(5):851-62. doi: 10.1002/stem.415.

PMID:
20309962
[PubMed - indexed for MEDLINE]
Free Article
18.

Glioblastoma cancer stem cells: role of the microenvironment and therapeutic targeting.

Persano L, Rampazzo E, Basso G, Viola G.

Biochem Pharmacol. 2013 Mar 1;85(5):612-22. doi: 10.1016/j.bcp.2012.10.001. Epub 2012 Oct 11. Review.

PMID:
23063412
[PubMed - indexed for MEDLINE]
19.

Knockdown of the potential cancer stem-like cell marker Rex-1 improves chemotherapeutic effects in gliomas.

Kim BS, Kang KS, Choi JI, Jung JS, Im YB, Kang SK.

Hum Gene Ther. 2011 Dec;22(12):1551-62. doi: 10.1089/hum.2011.096. Epub 2011 Sep 29.

PMID:
21810014
[PubMed - indexed for MEDLINE]
20.

Hypoxia and hypoxia-inducible factors in glioblastoma multiforme progression and therapeutic implications.

Yang L, Lin C, Wang L, Guo H, Wang X.

Exp Cell Res. 2012 Nov 15;318(19):2417-26. doi: 10.1016/j.yexcr.2012.07.017. Epub 2012 Aug 13. Review.

PMID:
22906859
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk